Specialty Rheumatology, Allergy and Immunology
-
Featured
Study Positions SGLT2 Inhibitors as Gout Treatment
A Massachusetts General Hospital research team has found that SGLT2 inhibitor therapy reduces gout flares and lowers the risk of myocardial infarction in patients with diabetes.
-
Innovations in Allergy Immunotherapy: Perspectives From Sarita Patil, MD
Food allergies represent a growing public health concern, affecting millions of individuals globally and posing significant clinical and quality-of-life challenges. However, their efficacy remains inconsistent, with only a subset of patients achieving long-term tolerance.
-
Pathways Case Record: An Immunocompetent Patient With Disseminated CMV
A 49-year-old male presented to Massachusetts General Hospital, found to have new heart failure with a reduced ejection fraction and pericardial effusion. Testing revealed elevated cytomegalovirus (CMV) viral load, so the Pathways Service investigated how a previously immunocompetent patient developed CMV reactivation.
-
Mass General Program One of the Few in the World to Focus on Vasculitis Patients
Sebastian Unizony, MD, and Zachary S. Wallace, MD, MSc, co-directors of the Vasculitis Program at Massachusetts General Hospital, discuss the program's multidisciplinary approach to care and pioneering research efforts.
-
Risk of Serious Infection Lower With Belimumab Than Oral Immunosuppressants When Treating Nonrenal Systemic Lupus Erythematosus
Using a nationwide database to identify 21,481 patients with nonrenal systemic lupus erythematosus, Emma Materne, MD, April Jorge, MD, and colleagues designed a hypothetical randomized trial. They found the risk of serious infection was 21% lower with belimumab than with azathioprine, methotrexate, or mycophenolate.
-
Pathways Case Record: Myositis Associated Interstitial Lung Disease
The Pathways Consult Service at Massachusetts General Hospital was consulted for the case of a 22-year-old man who was suspected to have rapidly progressive inflammatory disease leading to interstitial lung disease and myopathy leading to rhabdomyolysis. The Pathways team focused on the patient's inflammatory profile.
Rheumatology, Allergy and Immunology Contributors
-
Andrew D. Luster, MD, PhD
Chief of the Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Director of the Center for Immunology and Inflammatory Diseases
Recent Article
Efficient Early Immune Control of COVID-19 Predicts Favorable Long-term Adaptive Immunity
-
Hak Soo Choi, PhD
Director, Bioengineering and Nanomedicine Program, Massachusetts General Hospital, Associate Professor of Radiology, Harvard Medical School, Faculty, Dana-Farber/Harvard Cancer Center
Recent Article
Tissue-Specific Contrast Agents for Optical Fluorescence to Evaluate Rheumatoid Arthritis -
Hyon Choi, MD, DrPH
Director, Clinical Epidemiology and Health Outcomes Research, Division of Rheumatology, Allergy and Immunology, Clinical Rheumatologist, Department of Medicine, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School
Recent Article
Study Positions SGLT2 Inhibitors as Gout Treatment
-
John H. Stone, MD, MPH
Director, Clinical Rheumatology, Massachusetts General Hospital, Edward A. Fox Chair in Medicine at Mass General
Recent Article
Medical Grand Rounds: The Mass General Story of IgG4-related Disease
-
Kimberly G. Blumenthal, MD, MSc
Director of Research, Drug and Vaccine Allergy Center, Co-Director, Clinical Epidemiology Program, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Most Prior Drug Allergies Can Be Disproved in Older Adults
-
Wayne G. Shreffler, MD, PhD
Chief, Pediatric Allergy & Immunology, Director, Food Allergy Center, Principal Investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital
Recent Article
Key Allergic Mediators of Eosinophilic Esophagitis Identified -
Yuqing Zhang, ScD
Director of Epidemiological and Biostatistical Methods, Rheumatology Unit, Massachusetts General Hospital, Professor in Residence of Medicine, Harvard Medical School
Recent Article
Higher Hydroxychloroquine Dose Progressively Increases Incidence of Retinopathy -
Zachary S. Wallace, MD, MSc
Co-Director, Rheumatology Vasculitis Program, Physician, Rheumatology Unit, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Mass General Program One of the Few in the World to Focus on Vasculitis Patients
Rheumatology, Allergy and Immunology
The Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.